SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: KLH who wrote (2424)1/7/1999 5:22:00 PM
From: Steven C. Vartan  Respond to of 2553
 
Thanks for the report reference. A poster on Yahoo felt that this stock was like a "good" pyramid scheme. As docs get trained and bullish on procedure they will grow from doing one or two to ten plus and the growth would be exponential. He is a carticel patient. At least with a very strong Genzeme General the tracking stock won't go broke during the build up. Unfortunately we may need to wait to the millinium to make any money in this issue.



To: KLH who wrote (2424)1/7/1999 6:57:00 PM
From: Linda Kaplan  Respond to of 2553
 
Thanks. Important! --Linda



To: KLH who wrote (2424)1/8/1999 10:06:00 AM
From: KLH  Read Replies (2) | Respond to of 2553
 
It is very frustrating to see GZTC move back from the
recent 4s to trades in the 6s, while we are dead in the
water. Is it the price range we're now in that draws
no interest(implied lack of credibility)?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News